Bank Julius Baer & Co. Ltd, Zurich Boston Scientific Corp Transaction History

Bank Julius Baer & Co. Ltd, Zurich

$25.6 Billion
Q3 2024

A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Boston Scientific Corp stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 290,110 shares of BSX stock, worth $29.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

290,110

Previous 301,200 3.68%

Holding current value

$29.7 Million

Previous $23.2 Million 4.81%

% of portfolio

0.09%

Previous 0.1%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$72.96 - $84.0 $809,126 - $931,560	-11,090 Reduced 3.68%	290,110 $24.3 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $3.14 Million - $3.63 Million	-46,688 Reduced 13.42%	301,200 $23.2 Million
Q1 2024 May 14, 2024	BUY	$57.6 - $68.62 $9.16 Million - $10.9 Million	159,049 Added 84.22%	347,888 $23.8 Million
Q4 2023 May 16, 2024	SELL	$48.64 - $57.81 $9.93 Million - $11.8 Million	-204,124 Reduced 58.68%	143,764 $8.31 Million
Q4 2023 May 16, 2024	BUY	$48.64 - $57.81 $2.19 Million - $2.61 Million	45,075 Added 31.35%	188,839 $10.9 Million
Q4 2023 Feb 02, 2024	SELL	$48.64 - $57.81 $4.22 Million - $5.02 Million	-86,782 Reduced 31.49%	188,839 $10.9 Million
Q3 2023 Nov 13, 2023	SELL	$50.19 - $54.68 $718,018 - $782,252	-14,306 Reduced 4.93%	275,621 $14.6 Million
Q2 2023 Jul 24, 2023	BUY	$49.72 - $54.64 $14.4 Million - $15.8 Million	289,927 New	289,927 $15.7 Million
Q1 2023 May 11, 2023	BUY	$45.09 - $50.03 $811,935 - $900,890	18,007 Added 6.25%	305,997 $15.3 Million
Q4 2022 Jan 24, 2023	BUY	$39.56 - $47.22 $716,866 - $855,673	18,121 Added 6.71%	287,990 $13.3 Million
Q3 2022 Nov 04, 2022	SELL	$36.71 - $109.66 $139,020 - $415,282	-3,787 Reduced 1.38%	269,869 $10.5 Million
Q2 2022 Jul 22, 2022	BUY	$35.24 - $47.1 $158,121 - $211,337	4,487 Added 1.67%	273,656 $10.2 Million
Q1 2022 May 09, 2022	SELL	$40.9 - $45.1 $613,909 - $676,951	-15,010 Reduced 5.28%	269,169 $11.9 Million
Q4 2021 Feb 15, 2022	SELL	$38.07 - $44.87 $1.07 Million - $1.26 Million	-28,176 Reduced 9.02%	284,179 $12.1 Million
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $1.05 Million - $1.17 Million	25,545 Added 8.91%	312,355 $13.6 Million
Q2 2021 Jul 23, 2021	BUY	$38.58 - $44.24 $882,440 - $1.01 Million	22,873 Added 8.67%	286,810 $12.3 Million
Q1 2021 May 10, 2021	BUY	$35.27 - $39.67 $2.37 Million - $2.67 Million	67,303 Added 34.23%	263,937 $10.2 Million
Q4 2020 Feb 24, 2021	BUY	$33.15 - $41.97 $4.79 Million - $6.06 Million	144,389 Added 276.37%	196,634 $7.07 Million
Q4 2020 Feb 12, 2021	SELL	$33.15 - $41.97 $3.92 Million - $4.96 Million	-118,281 Reduced 69.36%	52,245 $7.07 Million
Q3 2020 Nov 10, 2020	SELL	$34.44 - $42.23 $3.03 Million - $3.72 Million	-88,045 Reduced 34.05%	170,526 $6.52 Million
Q2 2020 Aug 12, 2020	BUY	$30.19 - $39.11 $7.81 Million - $10.1 Million	258,571 New	258,571 $9.08 Million

Others Institutions Holding BSX

# of Institutions

1,580

Shares Held

1.19B

Call Options Held

6.82M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Account

Bank Julius Baer & Co. Ltd, Zurich Boston Scientific Corp Transaction History